_:nfe001f8a7d18412a8e2bd363a33a1daaxb2
<http://schema.org/description>
"Karyopharm Therapeutics traded at $5.32 this Wednesday September 28th, increasing $0.68 or 14.66 percent since the previous trading session. Looking back, over the last four weeks, Karyopharm Therapeutics gained 3.50 percent. Over the last 12 months, its price fell by 9.68 percent. Looking ahead, we forecast Karyopharm Therapeutics                                                                              to be priced at 4.27 by the end of this quarter and at 3.90 in one year, according to Trading Economics global macro models projections and analysts expectations. "
<https://d3fy651gv2fhd3.cloudfront.net/kpti:us>